Balanced news tone
News Sentiment
EMD sentiment intelligence
Emyria Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
19 relevant articles
Price is moving more forcefully than the current news tone suggests.
91/100 classification confidence.
directly relevant articles
high-authority source matches
-7.3% over one week, -9.5% over four weeks, trend inactive, and below fair value.
Top ASX Cannabis Stock to Watch: Can Emyria (ASX:EMD) Stay Ahead as Rules Tighten?
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
91/100 classification
One-week reaction
-7.3%
Price reacting lower
Trend fit
Trend inactive
-9.5% over four weeks
Fair value
-23.8%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
16
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Kalkine Media
Direct company coverage
Top ASX Cannabis Stock to Watch: Can Emyria (ASX:EMD) Stay Ahead as Rules Tighten?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 06:19
- Source
- Kalkine Media
Kalkine Media
Direct company coverage
Top Reasons Emyria (ASX:EMD) Is Expanding Beyond Cannabis Into Psychedelic Care
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 06:28
- Source
- Kalkine Media
simplywall.st
Direct company coverage
Here's Why We're Not Too Worried About Emyria's (ASX:EMD) Cash Burn Situation
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 04 Jul 2026 07:00
- Source
- simplywall.st
Kalkine
Direct company coverage
Emyria (ASX: EMD) Reports Encouraging Early Depression Data as Second Treatment Program Advances
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Kalkine
The Australian
Direct company coverage
Early findings emerge from Emyria depression program
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- The Australian
Kalkine
Direct company coverage
Emyria (ASX: EMD) Posts Early Wins in Treatment-Resistant Depression
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Kalkine
Kalkine
Direct company coverage
What Does NSW Expansion Mean For Emyria's (ASX:EMD) Growth Strategy?
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Kalkine
The Australian
Direct company coverage
Emyria launches clinical workforce recruitment drive
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Apr 2026 07:00
- Source
- The Australian
Kalkine
Direct company coverage
Emyria (ASX:EMD) Shares Under Pressure Despite Expansion-Driven Growth Update
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- Kalkine
smallcaps.com.au
Direct company coverage
Insights: Emyria Ltd (ASX:EMD)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Oct 2025 14:17
- Source
- smallcaps.com.au
Stocks Down Under
Direct company coverage
Emyria’s (ASX:EMD) commercial breakthrough in psychedelic medicine
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Sep 2025 07:00
- Source
- Stocks Down Under
Market source
Direct company coverage
Emyria Full Year 2025 Earnings: AU$0.007 loss per share (vs AU$0.032 loss in FY 2024)
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 29 Aug 2025 07:00
- Source
- Market source
Investing News Network
Direct company coverage
Medibank to Fund Emyria’s PTSD Program at Perth Clinic
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2025 07:00
- Source
- Investing News Network
Investing News Network
Direct company coverage
Eminent Healthcare Leader Appointed as Independent Non-Executive Chairman for Emyria Ltd
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Nov 2023 08:00
- Source
- Investing News Network
Next Investors
Direct company coverage
Our Newest Investment is Emyria (ASX: EMD)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Sep 2023 07:00
- Source
- Next Investors
BiotechDispatch
Direct company coverage
Emyria to expand MDMA programs following TGA psychedelic decision
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Feb 2023 08:00
- Source
- BiotechDispatch
Tattarang
Direct company coverage
Tattarang invests in Australian medicinal cannabis innovator Emyria
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Nov 2021 08:00
- Source
- Tattarang
intelligentinvestor.com.au
Direct company coverage
Emyria Limited (ASX: EMD) - Share Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Sep 2020 04:36
- Source
- intelligentinvestor.com.au
TradingView
Direct company coverage
EMD Stock Price and Chart — ASX:EMD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Feb 2020 21:41
- Source
- TradingView